• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Pragmatic Free Trial Meta

Pragmatic Free Trial Meta is a non-commercial open data platform and infrastructure that facilitates research on pragmatic trials. It gathers and distributes clean trial data, ratings and evaluations using PRECIS-2. This allows for a variety of meta-epidemiological studies to compare treatment effect estimates across trials of various levels of pragmatism.

Background

Pragmatic trials provide evidence from the real world that can be used to make clinical decisions. However, the use of the term "pragmatic" is inconsistent and its definition and evaluation requires clarification. Pragmatic trials are intended to guide the practice of clinical medicine and policy choices, rather than prove a physiological or clinical hypothesis. A pragmatic trial should aim to be as close as possible to actual clinical practices that include recruitment of participants, setting up, implementation and delivery of interventions, determination and analysis outcomes, and primary analysis. This is a key distinction from explanatory trials (as described by Schwartz and Lellouch1) that are designed to provide more complete confirmation of a hypothesis.

Studies that are truly pragmatic should avoid attempting to blind participants or healthcare professionals in order to cause bias in the estimation of the effects of treatment. Pragmatic trials will also recruit patients from various health care settings to ensure that their results can be generalized to the real world.

Additionally, pragmatic trials should focus on outcomes that are crucial to patients, like quality of life or functional recovery. This is particularly important in trials that involve surgical procedures that are invasive or have potential serious adverse events. The CRASH trial29, for instance was focused on functional outcomes to compare a two-page report with an electronic system for monitoring of patients admitted to hospitals with chronic heart failure. Similarly, the catheter trial28 focused on symptomatic catheter-associated urinary tract infections as its primary outcome.

In addition to these characteristics, pragmatic trials should minimize the trial's procedures and data collection requirements to reduce costs. Finally pragmatic trials should strive to make their results as applicable to clinical practice as they can by making sure that their primary method of analysis follows the intention-to treat approach (as described in CONSORT extensions for pragmatic trials).

Despite these criteria, many RCTs with features that challenge the concept of pragmatism have been mislabeled as pragmatic and published in journals of all kinds. This can lead to false claims of pragmaticity and the usage of the term needs to be standardized. The creation of a PRECIS-2 tool that offers an objective and standardized assessment of pragmatic features is a first step.

Methods

In a pragmatic study it is the intention to inform policy or clinical decisions by demonstrating how an intervention could be integrated into routine treatment in real-world settings. Explanatory trials test hypotheses about the cause-effect relationship within idealised settings. In this way, pragmatic trials could have lower internal validity than studies that explain and be more susceptible to biases in their design as well as analysis and conduct. Despite these limitations, pragmatic trials can provide valuable information to decision-making in the context of healthcare.

The PRECIS-2 tool evaluates the degree of pragmatism in an RCT by assessing it on 9 domains that range from 1 (very explicative) to 5 (very pragmatic). In this study, the areas of recruitment, organization as well as flexibility in delivery flexible adherence, and follow-up scored high. However, the primary outcome and method of missing data was scored below the pragmatic limit. This indicates that a trial can be designed with effective practical features, yet not damaging the quality.

It is hard to determine the amount of pragmatism that is present in a trial since pragmatism doesn't have a single characteristic. Some aspects of a study can be more pragmatic than others. A trial's pragmatism can be affected by changes to the protocol or the logistics during the trial. In addition, 36% of the 89 pragmatic trials identified by Koppenaal and colleagues were placebo-controlled, or conducted prior to licensing, and the majority were single-center. They aren't in line with the standard practice and are only referred to as pragmatic if the sponsors agree that these trials are not blinded.

Furthermore, a common feature of pragmatic trials is that the researchers try to make their results more relevant by analyzing subgroups of the trial. This can result in unbalanced analyses that have less statistical power. This increases the possibility of missing or misdetecting differences in the primary outcomes. This was a problem in the meta-analysis of pragmatic trials as secondary outcomes were not adjusted for differences in covariates at the baseline.

In addition, pragmatic studies may pose challenges to gathering and interpretation of safety data. This is due to the fact that adverse events are typically self-reported and are susceptible to errors, delays or coding differences. Therefore, it is crucial to enhance the quality of outcomes for these trials, in particular by using national registry databases instead of relying on participants to report adverse events on a trial's own database.

Results

While the definition of pragmatism does not require that all trials be 100 percent pragmatic, there are some advantages of including pragmatic elements in clinical trials. These include:

Increased sensitivity to real-world issues, reducing cost and size of the study, and enabling the trial results to be more quickly translated into actual clinical practice (by including patients from routine care). But pragmatic trials can be a challenge. The right kind of heterogeneity, for example could help a study generalise its findings to many different settings or patients. However, the wrong type can decrease the sensitivity of the test and thus decrease the ability of a study to detect small treatment effects.

Numerous studies have attempted to categorize pragmatic trials, using various definitions and scoring systems. Schwartz and Lellouch1 developed a framework to differentiate between explanation studies that support the physiological hypothesis or clinical hypothesis, and pragmatic studies that help inform the choice for appropriate therapies in real world clinical practice. The framework consisted of nine domains assessed on a scale of 1-5 which indicated that 1 was more informative and 5 was more pragmatic. The domains were recruitment setting, setting, intervention delivery, flexible adherence, follow-up and primary analysis.

The original PRECIS tool3 was based on a similar scale and domains. Koppenaal and colleagues10 created an adaptation of the assessment, known as the Pragmascope that was simpler to use for systematic reviews. They found that pragmatic systematic reviews had higher average scores across all domains but lower scores in the primary analysis domain.

This distinction in the primary analysis domain can be due to the way in which most pragmatic trials analyze data. Some explanatory trials, however don't. The overall score for systematic reviews that were pragmatic was lower when the areas of organization, flexible delivery, and following-up were combined.

It is important to remember that a pragmatic study does not necessarily mean a low-quality study. In fact, there is a growing number of clinical trials which use the term "pragmatic" either in their abstract or 프라그마틱 슬롯 체험 무료프라그마틱 체험 (please click the following internet page) title (as defined by MEDLINE however it is neither precise nor sensitive). The use of these words in abstracts and 프라그마틱 무료슬롯 titles could suggest a greater awareness of the importance of pragmatism but it isn't clear if this is evident in the content of the articles.

Conclusions

In recent years, pragmatic trials have been becoming more popular in research as the importance of real-world evidence is becoming increasingly acknowledged. They are randomized studies that compare real-world alternatives to experimental treatments in development. They involve patient populations that are more similar to those who receive treatment in regular medical care. This method is able to overcome the limitations of observational research, such as the biases associated with the reliance on volunteers, and the limited availability and codes that vary in national registers.

Other benefits of pragmatic trials include the ability to utilize existing data sources, and a greater likelihood of detecting meaningful changes than traditional trials. However, they may have some limitations that limit their effectiveness and generalizability. Participation rates in some trials could be lower than anticipated because of the healthy-volunteering effect, financial incentives, or competition from other research studies. The need to recruit individuals in a timely manner also restricts the sample size and impact of many pragmatic trials. In addition certain pragmatic trials lack controls to ensure that the observed differences aren't due to biases in trial conduct.

The authors of the Pragmatic Free Trial Meta identified 48 RCTs self-labeled as pragmatic and that were published from 2022. They evaluated pragmatism using the PRECIS-2 tool, which consists of the eligibility criteria for domains, recruitment, flexibility in intervention adherence and follow-up. They discovered that 14 of the trials scored as highly or pragmatic practical (i.e. scores of 5 or more) in any one or more of these domains, and that the majority of these were single-center.

Trials that have high pragmatism scores tend to have more criteria for eligibility than traditional RCTs. They also include populations from various hospitals. According to the authors, could make pragmatic trials more useful and relevant to the daily practice. However, they don't ensure that a study is free of bias. In addition, the pragmatism that is present in a trial is not a definite characteristic and a pragmatic trial that does not contain all the characteristics of an explanatory trial can produce valuable and reliable results.